Granulomatous interstitial nephritis secondary to the use of the anti-TNF adalimumab / Nefritis intersticial granulomatosa secundario al uso del anti TNF adalimumab
Acta méd. colomb
; 46(3): 67-69, jul.-set. 2021. tab, graf
Article
in English
|
LILACS-Express
| LILACS
| ID: biblio-1383310
Responsible library:
CO304.1
ABSTRACT
Abstract We present the case of a 56-year-old patient with progressive kidney function deterioration whose kidney biopsy reported granulomatous interstitial nephritis. The medical chart was reviewed, and it was noted that the deterioration coincided with the initiation of the medication adalimumab. It was discontinued and steroid plus cytostatic treatment was begun, with improvement. (Acta Med Colomb 2021; 46. DOIhttps//doi.org/10.36104/amc.2021.2050).
RESUMEN
Resumen Se presenta el caso de una paciente de 56 años, quien presenta deterioro progresivo en la función renal, y en quien la biopsia renal reportó nefritis intersticial granulomatosa. Se revisó historia clínica, y se detectó que el deterioro coincidía con el inicio del medicamento adalimumab. Se suspendió, inicio terapia de esteroide más citostático con mejoría. (Acta Med Colomb 2021; 46. DOIhttps//doi.org/10.36104/amc.2021.2050).
Full text:
Available
Collection:
International databases
Database:
LILACS
Language:
English
Journal:
Acta méd. colomb
Journal subject:
Medicine
Year:
2021
Document type:
Article
Affiliation country:
Colombia
Institution/Affiliation country:
Hospital Universitario Fundación Santa Fe/CO
/
Universidad de Caldas/CO